Document is current
Any future updates will be listed below
-
Authors
Tanaka, Yuki
Kadota, Shin https://orcid.org/0000-0001-9010-7079
Zhao, Jian
Kobayashi, Hideki
Okano, Satomi
Izumi, Masaki
Honda, Yusuke
Ichimura, Hajime
Shiba, Naoko
Uemura, Takeshi
Wada, Yuko
Chuma, Shinichiro
Nakada, Tsutomu
Tohyama, Shugo
Fukuda, Keiichi
Yamada, Mitsuhiko
Seto, Tatsuichiro
Kuwahara, Koichiro
Shiba, Yuji https://orcid.org/0000-0002-0311-2919
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (KAKENHI 17H06724, KAKENHI 19K17554, KAKENHI 17H04173, KAKENHI 18K19539, KAKENHI 21K08100, KAKENHI 21H02910)
MSD Life Science Foundation, Public Interest Incorporated Foundation
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
- License Information
-
More Information
Article History
Received: 4 November 2022
Accepted: 22 August 2023
First Online: 7 September 2023
Declarations
:
: All rats used in this study received humane care in compliance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. This study was performed in accordance with the Guidelines for Animal Experimentation of Shinshu University. The use of animals has been approved by the Committee for Animal Experimentation of Shinshu University. The approved project is Investigation of pluripotent stem cell-derived cardiomyocyte maturation; Approval numbers: 290010, Aug 9, 2017, and 019131, Apr 1, 2020. The manuscript adheres to the ARRIVE guidelines () for the reporting of animal experiments.
: Not applicable.
: K.F. is a cofounder and CEO of Heartseed, Inc. S.T. is an advisor for Heartseed, Inc. S.T. and K.F. own equity in Heartseed, Inc. All other authors declare that they have no competing interest.
